Navigation Links
About 60 Clinical Studies Regarding Schering-Plough's Oncology Compounds Will be Presented at ASCO
Date:5/30/2008

KENILWORTH, N.J., May 30 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) announced today that about 80 posters, poster discussions, and oral presentations from about 60 clinical studies relating to its growing oncology franchise will be presented at the upcoming 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 30 - June 3. Data will be presented on TEMODAR(R) (temozolomide) Capsules, CAELYX(R) (pegylated liposomal doxorubicin hydrochloride), INTRON(R) A (Interferon alfa-2b, recombinant) for Injection and peginterferon alfa-2b, as well as the company's investigational oncology compounds including SCH 727965.

-- TEMODAR(R): Twenty-eight abstracts will be presented, including 10

poster discussions and eight oral presentations.

-- CAELYX(R): Eleven abstracts will be presented, including two poster

discussions and two oral presentations.

-- INTRON(R) A and peginterferon alfa-2b: Data will be featured in more

than 10 abstracts, including five poster discussions and five oral

presentations.

Please see important full U.S. Prescribing Information, and the Medication Guides for INTRON(R) A and peginterferon alfa-2b at http://www.schering-plough.com.

Schering-Plough Corp. has exclusive ex-U.S. marketing rights to CAELYX(R), except in Japan and Israel, through a distribution agreement with ALZA, a wholly owned subsidiary of Johnson & Johnson, New Brunswick, N.J., USA. The product is marketed in the United States under the tradename DOXIL(R) by Ortho Biotech Products, L.P. Full EU Prescribing Information may be accessed at

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. The Anatomy of Clinical Trials: Greys Season Finale Leaves Public in the Dark About the Myths and Realities
2. Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids
3. Second Thoughts about Fluoride, Reports Scientific American
4. Bonnie Blair to Break the Ice About Stress Urinary Incontinence in Milwaukee
5. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
6. Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
7. Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors
8. Vion Pharmaceuticals to Present Clinical Data on Cloretazine(R) (VNP40101M) at the ASCO(R) Annual Meeting
9. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
10. AMT Announces Positive Interim Clinical Data on its Lead Product AMT-011
11. Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015   Mast ... biopharmaceutical company leveraging its molecular adhesion and sealant ... sickle cell disease, heart failure, and arterial disease, ... EPIC study of its lead product ... surpassed the halfway point. Consistent with prior guidance, ...
(Date:4/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/5jt68c/global_api_market ) has ... 2018" report to their offering. Global API ... the Global API industry is expected to grow at a ... been divided into four major geographies which comprise Americas, ... the rest of the world. For every region, a current ...
(Date:4/21/2015)... MENLO PARK, Calif. , April 21, 2015 /PRNewswire/ ... company focused on the emerging field of regenerative medicine, ... patients with acute myelogenous leukemia (AML) from the Phase ... cell cancer vaccine, AST-VAC1, has been selected for an ... Oncology (ASCO) Annual Meeting, to be held in ...
Breaking Medicine Technology:Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 2Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 3Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 4Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 5Global API Market Outlook Report 2014-2018 2Global API Market Outlook Report 2014-2018 3Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 2Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 3
... , ... Albemarle Corporation (NYSE: ALB ), a leading global ... PharmaCore to provide manufacturing capabilities for customers with projects that require ... alliance allows a seamless technology transfer from PharmaCore to Albemarle ...
... , ... Systems, Inc. today announced full integration between AVImark veterinary software ... the two-way connection allows diagnostic test requisitions and patient data ... any AVImark workstation in a veterinary practice. Test results are ...
Cached Medicine Technology:Albemarle(R) Announces Custom Manufacturing Alliance with PharmaCore(R) 2Albemarle(R) Announces Custom Manufacturing Alliance with PharmaCore(R) 3Albemarle(R) Announces Custom Manufacturing Alliance with PharmaCore(R) 4Albemarle(R) Announces Custom Manufacturing Alliance with PharmaCore(R) 5McAllister Software Systems, Inc. and IDEXX Laboratories, Inc. Announce Availability of the IDEXX VetLab(R) Station InterLink(TM) Connection to AVImark(R) 2010 2McAllister Software Systems, Inc. and IDEXX Laboratories, Inc. Announce Availability of the IDEXX VetLab(R) Station InterLink(TM) Connection to AVImark(R) 2010 3McAllister Software Systems, Inc. and IDEXX Laboratories, Inc. Announce Availability of the IDEXX VetLab(R) Station InterLink(TM) Connection to AVImark(R) 2010 4
(Date:4/21/2015)... The American Society for Dermatologic Surgery is ... Brandt, M.D., by setting up two memorial funds in ... 1982, died earlier this month at age 65 at ... opportunities for ASDS members, industry and any interested donors ... Brandt held so dear. , “Dr. Brandt was one ...
(Date:4/21/2015)... 2015 NOVAtime Technology, Inc. ( ... and Attendance / Workforce Management solutions, announced its ... American Payroll Association (APA) as well as NetSuite’s ... has been the nation’s payroll authority since 1982, ... and recertification credits. Held at the MGA Grand ...
(Date:4/21/2015)... Saint Louis, MO (PRWEB) April 21, 2015 ... April 29, 2015 from 5:00 to 8:00 pm at the ... Center Drive, Chapel Hill, NC 27599. More than 50 hospitals, ... across the country. All specialties will be represented. Attendees will ... Thompson, Director of Career Fairs for PracticeMatch says ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Atlantic ... the launch of Medicare-Medicaid Dual Eligibles Database, a ... on care provided to the more than 9 ... account for more than $300 billion in annual ... – the same team that also creates the ...
(Date:4/21/2015)... eSight is the only technology in the world that helps ... May 5th, Low Vision Specialists of Maryland and Virginia ... unveiling and demonstration of the technology at 8:30 a.m at ... be the first ophthalmic practice in Maryland to offer the ... be available on the day of the unveiling. , How ...
Breaking Medicine News(10 mins):Health News:ASDS honors the legacy of Dr. Fredric Brandt 2Health News:ASDS honors the legacy of Dr. Fredric Brandt 3Health News:ASDS honors the legacy of Dr. Fredric Brandt 4Health News:NOVAtime Participates in 2015 APA Congress and NetSuite SuiteWorld Conferences in May 2Health News:NOVAtime Participates in 2015 APA Congress and NetSuite SuiteWorld Conferences in May 3Health News:PracticeMatch to Host Physician Career Fair at William and Ida Friday Center at UNC-Chapel Hill on April 29, 2015 2Health News:PracticeMatch to Host Physician Career Fair at William and Ida Friday Center at UNC-Chapel Hill on April 29, 2015 3Health News:New AIS Database Tracks All Programs, Plans Serving the Dual-Eligible Community 2Health News:eSight Electronic Glasses That Enable The Legally Blind To See – First In The World – Coming To Maryland 2Health News:eSight Electronic Glasses That Enable The Legally Blind To See – First In The World – Coming To Maryland 3
... Study Reveals the Most Common Reasons Why Total Hip ... thousands of patients undergo total hip replacement surgery in ... disease and other related hip problems. According to ... of The Journal of Bone and Joint Surgery ...
... Jan. 2 Joan Lunden, the nation,s,longest-running morning ... two decades. During her tenure she reported ... two Royal weddings. One of the most,visible ... of her career to,educating Americans about health and ...
... ATLANTA, Jan. 2 Publix, Procter & Gamble, and,Special ... people with,intellectual disabilities achieve their dreams. Now they,re ... Special Olympics. , 1. Support ... by,purchasing your favorite P&G products like Tide, Pampers, Bounty ...
... tips on how to avoid injury while performing winter ... snow from your driveway and sidewalks can be physically ... proper health and safety precautions, says the American Academy ... than 118,000 people were treated in U.S. hospital emergency ...
... keep colds and flu at bay , , FRIDAY, Jan. 2 ... there,s one tidbit that doctors stand by as the best way ... free of germs is one of the simplest and most effective ... other infectious disease, experts say. , "Disease transmission is hand-to-hand combat, ...
... Va.In a study to determine the diagnostic value of ... cancer, researchers were able for the first time to ... and normal residual thyroid tissue directly after surgery. , ... an article in the January issue of The ...
Cached Medicine News:Health News:Replacing Your Total Hip Replacement 2Health News:Replacing Your Total Hip Replacement 3Health News:Joan Lunden Inks Three-Year Deal to Host Health Corner(R) Television Series 2Health News:'Be A Fan' of Special Olympics Throughout January 2Health News:Shovel Snow Safely 2Health News:To Protect Yourself, Wash Those Germs Away 2Health News:To Protect Yourself, Wash Those Germs Away 3Health News:To Protect Yourself, Wash Those Germs Away 4Health News:Molecular imaging enables earlier, individualized treatment of thyroid cancer 2
The DuraSeal System includes an innovative polyethylene glycol hydrogel sealant and applicator packaged in a single-use kit which can be stored at room temperature for convenience and quick preparati...
Mastisol Liquid Adhesive is a clear, non-irritating, and non-water-soluble liquid adhesive that secures the most difficult dressings for an extended period of time. Mastisol is 7 to 10 times stickier...
GluStitch® is indicated for the closure of uncomplicated skin lacerations where there is little or no tissue loss....
... GE Healthcare is ... in best-in-class analysis programs ... area monitoring device. With ... 12SL, Gender-Specific, and ACI-TIPI, ...
Medicine Products: